PTC Therapeutics Stock Options
| PTCT Stock | USD 25.41 0.56 2.16% |
PTC Therapeutics' option chain provides insight into all available option contracts written on PTC Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of PTC Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given PTC option contract.
In The Money vs. Out of Money Option Contracts on PTC Therapeutics
Analyzing PTC Therapeutics' in-the-money options over time can help investors to take a profitable long position in PTC Therapeutics regardless of its overall volatility. This is especially true when PTC Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money PTC Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with PTC Therapeutics' stock while costing only a fraction of its price.
PTC Therapeutics' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 72.79 with a put-to-call open interest ratio of 0.09 over 48 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 4. This yields a 0.0 put-to-call volume ratio. The PTC Therapeutics option chain provides detailed quote and price information for the current PTC Therapeutics option contracts. It shows all of PTC Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
PTC Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in PTC Therapeutics' lending market. For example, when PTC Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on PTC Therapeutics, he or she must hedge the risk by shorting PTC Therapeutics stock over its option's life.
2024-05-17
The chart above shows PTC Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. PTC Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for PTC Therapeutics' option, there is no secondary market available for investors to trade.
PTC Therapeutics Maximum Pain Price across 2024-05-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as PTC Therapeutics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
PTC Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of PTC Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell PTC stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If PTC Therapeutics' stock price goes up or down, the stock options follow.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PTC Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Please note that buying 'in-the-money' options on PTC Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if PTC Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money PTC Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if PTC Stock moves the wrong way.
At this time, PTC Therapeutics' Other Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 137.8 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 49.7 M in 2024. PTC Therapeutics In The Money Call Balance
When PTC Therapeutics' strike price is surpassing the current stock price, the option contract against PTC Therapeutics stock is said to be in the money. When it comes to buying PTC Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on PTC Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
PTC Current Options Market Mood
PTC Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps PTC Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of PTC Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. PTC Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current PTC Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current PTC contract
Base on the Rule 16, the options market is currently suggesting that PTC Therapeutics will have an average daily up or down price movement of about 4.55% per day over the life of the 2024-05-17 option contract. With PTC Therapeutics trading at USD 25.41, that is roughly USD 1.16. If you think that the market is fully incorporating PTC Therapeutics' daily price movement you should consider buying PTC Therapeutics options at the current volatility level of 72.79%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
PTC |
Purchasing PTC Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" PTC calls. Remember, the seller must deliver PTC Therapeutics stock to the call owner when a call is exercised.
PTC Therapeutics Option Chain
When PTC Therapeutics' strike price is surpassing the current stock price, the option contract against PTC Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
PTC Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on PTC. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for PTC. It also shows strike prices and maturity days for a PTC Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $15.0 | 0.8875 | 0.0131 | 0 | 2024-05-17 | 10.0 - 13.0 | 0.0 | In |
Call | 2024-05-17 CALL at $19.0 | 0.8332 | 0.026 | 0 | 2024-05-17 | 6.0 - 9.0 | 0.0 | In |
Call | 2024-05-17 CALL at $20.0 | 0.814 | 0.0315 | 0 | 2024-05-17 | 5.5 - 7.5 | 0.0 | In |
Call | 2024-05-17 CALL at $21.0 | 0.7709 | 0.0352 | 0 | 2024-05-17 | 4.6 - 7.1 | 0.0 | In |
Call | 2024-05-17 CALL at $22.0 | 0.8007 | 0.0556 | 0 | 2024-05-17 | 3.7 - 4.5 | 0.0 | In |
Call | 2024-05-17 CALL at $23.0 | 0.7244 | 0.0627 | 0 | 2024-05-17 | 3.1 - 3.9 | 0.0 | In |
Call | 2024-05-17 CALL at $24.0 | 0.645 | 0.0611 | 0 | 2024-05-17 | 2.05 - 4.3 | 0.0 | In |
Call | 2024-05-17 CALL at $25.0 | 0.5785 | 0.0764 | 0 | 2024-05-17 | 1.35 - 3.2 | 0.0 | In |
Call | 2024-05-17 CALL at $26.0 | 0.4914 | 0.0884 | 1 | 2024-05-17 | 1.15 - 2.0 | 1.4 | Out |
Call | 2024-05-17 CALL at $27.0 | 0.41 | 0.0848 | 10 | 2024-05-17 | 0.5 - 1.95 | 4.27 | Out |
Call | 2024-05-17 CALL at $28.0 | 0.3312 | 0.0801 | 406 | 2024-05-17 | 0.2 - 1.6 | 1.1 | Out |
Call | 2024-05-17 CALL at $29.0 | 0.2697 | 0.0712 | 6 | 2024-05-17 | 0.5 - 1.1 | 0.7 | Out |
Call | 2024-05-17 CALL at $30.0 | 0.173 | 0.0633 | 15 | 2024-05-17 | 0.2 - 0.5 | 0.6 | Out |
Call | 2024-05-17 CALL at $31.0 | 0.1931 | 0.0534 | 12 | 2024-05-17 | 0.1 - 0.9 | 0.4 | Out |
Call | 2024-05-17 CALL at $32.0 | 0.1199 | 0.0438 | 4 | 2024-05-17 | 0.2 - 0.3 | 0.3 | Out |
Call | 2024-05-17 CALL at $33.0 | 0.089 | 0.0353 | 0 | 2024-05-17 | 0.1 - 0.25 | 0.0 | Out |
Call | 2024-05-17 CALL at $34.0 | 0.0835 | 0.031 | 0 | 2024-05-17 | 0.1 - 0.25 | 0.0 | Out |
Call | 2024-05-17 CALL at $35.0 | 0.079 | 0.0277 | 1 | 2024-05-17 | 0.05 - 0.3 | 0.15 | Out |
Put | 2024-05-17 PUT at $19.0 | -0.0735 | 0.025 | 0 | 2024-05-17 | 0.15 - 0.25 | 0.0 | Out |
Put | 2024-05-17 PUT at $20.0 | -0.1059 | 0.034 | 0 | 2024-05-17 | 0.25 - 0.35 | 0.0 | Out |
Put | 2024-05-17 PUT at $21.0 | -0.1537 | 0.0441 | 0 | 2024-05-17 | 0.35 - 0.6 | 0.0 | Out |
Put | 2024-05-17 PUT at $22.0 | -0.2372 | 0.0489 | 0 | 2024-05-17 | 0.55 - 1.45 | 0.0 | Out |
Put | 2024-05-17 PUT at $23.0 | -0.2908 | 0.057 | 0 | 2024-05-17 | 0.75 - 1.75 | 0.0 | Out |
Put | 2024-05-17 PUT at $24.0 | -0.34 | 0.0769 | 0 | 2024-05-17 | 1.05 - 1.35 | 0.0 | Out |
Put | 2024-05-17 PUT at $25.0 | -0.4228 | 0.0835 | 0 | 2024-05-17 | 0.8 - 2.45 | 0.0 | Out |
Put | 2024-05-17 PUT at $26.0 | -0.5113 | 0.0893 | 0 | 2024-05-17 | 1.35 - 2.8 | 0.0 | In |
Put | 2024-05-17 PUT at $27.0 | -0.6084 | 0.0927 | 0 | 2024-05-17 | 2.15 - 3.0 | 0.0 | In |
Put | 2024-05-17 PUT at $28.0 | -0.657 | 0.0764 | 13 | 2024-05-17 | 2.75 - 4.3 | 2.2 | In |
Put | 2024-05-17 PUT at $29.0 | -0.7038 | 0.0669 | 15 | 2024-05-17 | 3.6 - 5.2 | 2.5 | In |
Put | 2024-05-17 PUT at $30.0 | -0.6997 | 0.0544 | 12 | 2024-05-17 | 4.5 - 6.7 | 3.1 | In |
Put | 2024-05-17 PUT at $31.0 | -0.7583 | 0.0514 | 0 | 2024-05-17 | 5.5 - 7.1 | 0.0 | In |
Put | 2024-05-17 PUT at $32.0 | -0.7798 | 0.046 | 0 | 2024-05-17 | 6.3 - 8.2 | 0.0 | In |
Put | 2024-05-17 PUT at $33.0 | -0.7617 | 0.0407 | 0 | 2024-05-17 | 6.9 - 10.0 | 0.0 | In |
Put | 2024-05-17 PUT at $34.0 | -0.8165 | 0.0378 | 0 | 2024-05-17 | 8.1 - 10.2 | 0.0 | In |
Put | 2024-05-17 PUT at $35.0 | -0.8506 | 0.0936 | 0 | 2024-05-17 | 8.9 - 11.1 | 0.0 | In |
Put | 2024-05-17 PUT at $36.0 | -0.7866 | 0.0323 | 0 | 2024-05-17 | 9.9 - 13.0 | 0.0 | In |
Put | 2024-05-17 PUT at $37.0 | -0.8358 | 0.0299 | 0 | 2024-05-17 | 10.9 - 13.4 | 0.0 | In |
Put | 2024-05-17 PUT at $38.0 | -0.8258 | 0.0283 | 0 | 2024-05-17 | 12.1 - 14.4 | 0.0 | In |
Put | 2024-05-17 PUT at $39.0 | -0.8304 | 0.0268 | 0 | 2024-05-17 | 13.0 - 15.5 | 0.0 | In |
Put | 2024-05-17 PUT at $40.0 | -0.8211 | 0.0256 | 0 | 2024-05-17 | 14.2 - 16.5 | 0.0 | In |
Put | 2024-05-17 PUT at $45.0 | -0.8497 | 0.0205 | 0 | 2024-05-17 | 19.0 - 21.5 | 0.0 | In |
PTC Therapeutics Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
PTC Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in PTC Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
PTC Therapeutics Corporate Directors
PTC Therapeutics corporate directors refer to members of a PTC Therapeutics board of directors. The board of directors generally takes responsibility for the PTC Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of PTC Therapeutics' board members must vote for the resolution. The PTC Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Emma Reeve | Independent Director | Profile | |
| Stephanie Okey | Independent Director | Profile | |
| Ronald Renaud | Director | Profile | |
| Dawn Svoronos | Director | Profile |
Already Invested in PTC Therapeutics?
The danger of trading PTC Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of PTC Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than PTC Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile PTC Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether PTC Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if PTC Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ptc Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Ptc Therapeutics Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PTC Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.Note that the PTC Therapeutics information on this page should be used as a complementary analysis to other PTC Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for PTC Stock analysis
When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is PTC Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PTC Therapeutics. If investors know PTC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PTC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.37) | Revenue Per Share 12.531 | Quarterly Revenue Growth 0.834 | Return On Assets (0.12) | Return On Equity (77.40) |
The market value of PTC Therapeutics is measured differently than its book value, which is the value of PTC that is recorded on the company's balance sheet. Investors also form their own opinion of PTC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is PTC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PTC Therapeutics' market value can be influenced by many factors that don't directly affect PTC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PTC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if PTC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PTC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.